|
Magyar Reumatológusok Egyesülete |
|
MRE Északkelet-magyarországi Szekciójának XXII. Tudományos Ülése |
Rendezvény kezdete: 2010.04.16. | Rendezvény vége: 2010.04.16. |
Helyszín: 3529 Miskolc, Csabai kapu 6., City Hotel |
MRE Északkelet-magyarországi Szekciójának XXII. Tudományos Ülése 2010. április 16-án kerül megrendezésre, Miskolcon, a City Hotelben (3529 Miskolc, Csabai kapu 6.)
Fő téma: Újdonságok az autoimmun betegségekben
A rendezvény pontszerző, a pontérték megállapítása folyamatban van.
Szervezők:
Dr. Tamási László
Szent Ferenc Rehabilitációs Kórház
3529 Miskolc, Csabai kapu 42.
Tel: (06- 46) 555-800
E-mail: ltamasi@szferenc.hu
Dr. Nagy Katalin
Markhot Ferenc Kórház, Reumatológia
3300 Eger, Fürdő u. 4.
Tel: (06-70) 546-5393
E-mail: drnagykati@freemail.hu
A program megtekinthető a kapcsolódó dokumentumban. |
|
|
|
|
Magyar Immunológiai Társaság |
|
China Tregs/Th Subsets 2012 conference |
Rendezvény kezdete: 2012.10.13. | Rendezvény vége: 2012.10.16. |
Tudományos információ: Shuiping Jiang, Conference (Founder and President, UK) |
Helyszín: Shanghai, |
A rendezvény Web oldala: http://www.chinatregs.com/ |
Third International Conference on Regulatory T Cells and Th Subsets and Clinical Application in Human Disease
This conference will focuse on Tregs, Th subsets including Th17, Th9, Th22, and follicular T helper cells.
Invitation
Dear Colleague:
The Chinese Society for Immunology and the Conference Organizers take great pleasure in inviting you to participate at the Third International Conference on Regulatory T Cells and Th Subsets and Clinical Application in Human Diseases to be held on October 13-26, 2012, Shanghai, China.
The China Tregs/Th Subsets 2012 Shanghai Conference is shaping up to be one of the most exciting and important meetings in immunology in 2012. We are putting together a terrific program with an outstanding collection of speakers and discussion leaders to cover the diverse aspects of research and preclinical and clinical trials of regulatory T cells and Th subsets including Th17, Th9, Th22, and follicular T helper cells. More than 40 world class speakers will present state-of-the-art topics and there will be ample time for abstracts, posters and many informal discussions that will be the hallmark of this third international conference on regulatory T cells and Th subsets.
Shanghai is emerging as one of the most modern and dynamic cities in the 21st century. We hope that you will enjoy visiting the city of Shanghai with rich history and modern charisma.
Please visit the conference website for our program and conference updates at http://www.chinatregs.com. We hope that you will be able to accept our invitation, and join us for what promises to be a most fascinating meeting on regulatory T cells and Th subsets.
We look forward to greeting you in Shanghai.
Yours sincerely,
Shuiping Jiang, Ph. D
Conference Founder and President |
|
|
|
|
Magyar Immunológiai Társaság |
|
DC2012 - 12th International Symposium on Dendritic Cells |
Rendezvény kezdete: 2012.10.07. | Rendezvény vége: 2012.10.11. |
Munkahely neve: DC 2012 Secretariat |
Címe: 1F Haeoreum B/D 748-5 Yeoksam-dong
Gangnam-gu Seoul 135-925 Korea |
Tel: +82-2-577-8422,8423 |
Fax: +82-2-566-6087 |
E-mail: dc@people-x.com |
Helyszín: Korea, Daegu, EXCO Convention Center |
A rendezvény Web oldala: http://www.dc2012.kr/ |
The 12th International Symposium on Dendritic Cells
The DC2012 is hosted by the Korean Association of Immunologists and organized by the
Organizing Committee of the DC 2012.
The DC 2012 is anticipating more than 1,600 participants and industry representatives from 40
different countries. I truly believe that DC2012 would be the milestone for all of us to understand the
cutting-edge of research trends, to share valuable information and to build a network between
specialists in the field of dendritic cells.
Deadline of Abstract Submission is extended to June 30, 2012
re-registration: Extended to Sep. 14th, 2012!
Clinical Trial Satellite Meeting(Sponsored by JW CreaGene, BD)
*Date & Time: October 8~9, 2012 / 12:20~13:20
*Venue: 4F Auditorium, EXCO
*Confirmed Speakers:
1)TriMix Dentritic cell therapy in Melanoma - the Brussels`s experience
-Prof. Thielemans Kris (Vrije Universiteit Brussel, Belgium)
2)Applying Lessons learned from Provenge to the development of new immunotherapies for cancer
-Dr. James B. Trager (Dendreon Corporation, USA)
-The lunch will be served during the Clinical Trial Satellite Meeting.
-Maximum 300 persons can attend the meeting on a first-come, first-served basis. |
|
|
|